Chris Primiano
Chris is responsible for leading Karyopharm’s operations, business development and legal departments and has been with the Company since March 2014.
Prior to joining Karyopharm, Chris worked at multiple international law firms and led internal legal and business development departments. He was a Counsel at Wilmer Cutler Pickering Hale and Dorr LLP, a full-service multinational law firm, and he served as Vice President, Corporate Development, General Counsel and Secretary of GlassHouse Technologies, Inc., an information technology consulting company, where he led global legal operations and managed asset and subsidiary acquisition and sale activity. Chris began his career at Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP, a global law firm focused on venture capital and the emerging technology marketplace.
Chris received a Bachelor of Arts in Political Economy and English from Georgetown University, a Master of Business Administration from the Boston College Carroll School of Management and a Juris Doctor from Boston College Law School.
Sharon Huws
Sharon's key research interests lie in understanding the role that rumen microbes play in ruminant food security. Her research is strategically focused on understanding the functionality of rumen microbes—with the aim of addressing food security and human health—coupled with industrial biotechnology related to the rumen microbiome. Sharon also has a general interest in microbiomes and occasionally focuses attention on poultry, pig, and even human lung microbiomes.
Sharon coordinates the global & Rumen Microbial Genomics; network, is a senior editor for the journal Microbiome and editor-in-chief for its sister journal & Animal Microbiome.
Petra Roubos
Peter Falck
Paolo Trevisi
Olga Francino Marti
Ph.D. in Genetics from the Universitat Autònoma de Barcelona (UAB) with broad experience in molecular biology and animal genomics. Project Management and Innovation at the Molecular Genetics Veterinary Service (SVGM) of the UAB since its creation in 1996. Founding partner of Vetgenomics (2011), a technology-based company focused on genetic diagnostic and genomics.
With extensive experience in the design and implementation of new methodologies of genetic analysis as well as to their valorization. Responsible for numerous agreements and projects with companies of the pharmaceutical and agrigenomics fields and currently working in national and international collaborations on infectious diseases, pathogens, and microbiome characterization with NGS.
